Synlogic Inc (SYBX) - Net Assets
Based on the latest financial reports, Synlogic Inc (SYBX) has net assets worth $11.86 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($15.45 Million) and total liabilities ($3.58 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check SYBX intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $11.86 Million |
| % of Total Assets | 76.8% |
| Annual Growth Rate | N/A |
| 5-Year Change | -91.94% |
| 10-Year Change | -80.34% |
| Growth Volatility | 39.17 |
Synlogic Inc - Net Assets Trend (2013–2025)
This chart illustrates how Synlogic Inc's net assets have evolved over time, based on quarterly financial data. See Synlogic Inc (SYBX) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Synlogic Inc (2013–2025)
The table below shows the annual net assets of Synlogic Inc from 2013 to 2025. For live valuation and market cap data, see Synlogic Inc market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $11.86 Million | -6.96% |
| 2024-12-31 | $12.75 Million | -70.11% |
| 2023-12-31 | $42.66 Million | -48.37% |
| 2022-12-31 | $82.61 Million | -43.90% |
| 2021-12-31 | $147.27 Million | +27.91% |
| 2020-12-31 | $115.14 Million | -26.62% |
| 2019-12-31 | $156.91 Million | +26.44% |
| 2018-12-31 | $124.10 Million | +45.93% |
| 2017-12-31 | $85.04 Million | +40.90% |
| 2016-12-31 | $60.35 Million | -29.01% |
| 2015-12-31 | $85.02 Million | +277.30% |
| 2014-12-31 | $-47.95 Million | -60.30% |
| 2013-12-31 | $-29.91 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Synlogic Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 41185200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $12.00K | 0.10% |
| Other Components | $454.51 Million | 3831.30% |
| Total Equity | $11.86 Million | 100.00% |
Synlogic Inc Competitors by Market Cap
The table below lists competitors of Synlogic Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Adcore Inc
TO:ADCO
|
$7.49 Million |
|
Straits Inter Logistics Bhd
KLSE:0080
|
$7.49 Million |
|
Lekoil Limited
F:L5K
|
$7.49 Million |
|
Worksport Ltd
NASDAQ:WKSP
|
$7.50 Million |
|
Lombard et Medot SA
PA:MLCAC
|
$7.48 Million |
|
Mcnally Bharat Engineering Company Limited
NSE:MBECL
|
$7.48 Million |
|
Vital Energy Inc
V:VUX
|
$7.48 Million |
|
DEFSEC Technologies Inc.
NASDAQ:DFSC
|
$7.48 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Synlogic Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 12,751,000 to 11,863,000, a change of -888,000 (-7.0%).
- Net loss of 1,005,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-1.00 Million | -8.47% |
| Other Changes | $117.00K | +0.99% |
| Total Change | $- | -6.96% |
Book Value vs Market Value Analysis
This analysis compares Synlogic Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.74x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $-26.41 | $0.71 | x |
| 2014-12-31 | $-42.33 | $0.71 | x |
| 2015-12-31 | $118.78 | $0.71 | x |
| 2016-12-31 | $20.28 | $0.71 | x |
| 2017-12-31 | $189.69 | $0.71 | x |
| 2018-12-31 | $77.94 | $0.71 | x |
| 2019-12-31 | $77.72 | $0.71 | x |
| 2020-12-31 | $48.19 | $0.71 | x |
| 2021-12-31 | $39.92 | $0.71 | x |
| 2022-12-31 | $17.28 | $0.71 | x |
| 2023-12-31 | $6.56 | $0.71 | x |
| 2024-12-31 | $1.05 | $0.71 | x |
| 2025-12-31 | $0.96 | $0.71 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Synlogic Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -8.47%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.30x
- Recent ROE (-8.47%) is above the historical average (-52.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-3.44 Million |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-11.04 Million |
| 2015 | -29.39% | 0.00% | 0.00x | 1.07x | $-33.48 Million |
| 2016 | -43.52% | -5916.22% | 0.01x | 1.06x | $-32.30 Million |
| 2017 | -47.48% | -1652.09% | 0.02x | 1.17x | $-48.88 Million |
| 2018 | -39.03% | -1922.02% | 0.02x | 1.13x | $-60.84 Million |
| 2019 | -31.02% | -2188.44% | 0.01x | 1.20x | $-64.36 Million |
| 2020 | -49.10% | -10373.76% | 0.00x | 1.25x | $-68.05 Million |
| 2021 | -39.46% | -3313.45% | 0.01x | 1.19x | $-72.84 Million |
| 2022 | -80.07% | -5605.68% | 0.01x | 1.34x | $-74.41 Million |
| 2023 | -134.29% | -1699.26% | 0.04x | 1.77x | $-61.55 Million |
| 2024 | -183.19% | -291987.50% | 0.00x | 1.55x | $-24.63 Million |
| 2025 | -8.47% | 0.00% | 0.00x | 1.30x | $-2.19 Million |
Industry Comparison
This section compares Synlogic Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $155,285,360
- Average return on equity (ROE) among peers: -101.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Synlogic Inc (SYBX) | $11.86 Million | 0.00% | 0.30x | $7.49 Million |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-34.80 Million | 0.00% | 0.00x | $83.17 Million |
| Abcellera Biologics Inc (ABCL) | $830.51 Million | 14.32% | 0.21x | $1.61 Billion |
| Abeona Therapeutics Inc (ABEO) | $-26.99 Million | 0.00% | 0.00x | $321.39 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $266.97 Million | -19.62% | 0.16x | $155.29 Million |
| Abpro Holdings, Inc. (ABP) | $3.07 Million | -479.81% | 1.57x | $2.00 Million |
| Absci Corp (ABSI) | $179.13 Million | -57.56% | 0.19x | $1.01 Billion |
| Arbutus Biopharma Corp (ABUS) | $182.50 Million | -46.25% | 0.30x | $831.63 Million |
| ABVC Biopharma Inc (ABVC) | $4.59 Million | -357.76% | 1.38x | $35.10 Million |
| Abivax SA American Depositary Shares (ABVX) | $33.94 Million | -14.97% | 0.12x | $7.98 Billion |
| ACADIA Pharmaceuticals Inc (ACAD) | $113.93 Million | -49.49% | 0.18x | $3.66 Billion |
About Synlogic Inc
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases. Synlogic, Inc. is based in Winchester, Massachusetts.